Anthropometric and adiposity indicators and risk of type 2 diabetes: systematic review and dose-response meta-analysis of cohort studies

Abstract

Objective To present a comprehensive review of the association between measures of body weight, waist, and fat, and different ratios of these measures, and the risk of type 2 diabetes. Design Systematic review and dose-response meta-analysis of cohort studies. Data sources PubMed, Scopus, and Web of Science up to 1 May 2021. Review methods Cohort studies looking at the association between general or central adiposity and body fat content and the risk of type 2 diabetes in the general adult population were included. Two of the authors extracted the data in duplicate. Random effects dose-response meta-analyses were performed to estimate the degree of the associations. Curvilinear associations were modelled with a one stage weighted mixed effects meta-analysis. Results 216 cohort studies with 2.3 million individuals with type 2 diabetes among 26 million participants were identified. Relative risks were 1.72 (95% confidence interval 1.65 to 1.81; n=182 studies) for an increase in body mass index of 5 units, 1.61 (1.52 to 1.70; n=78) for a 10 cm larger waist circumference, 1.63 (1.50 to 1.78; n=34) for an increase in waist-to-hip ratio of 0.1 units, 1.73 (1.51 to 1.98; n=25) for an increase in waist-to-height ratio of 0.1 units, 1.42 (1.27 to 1.58; n=9) for an increase in visceral adiposity index of 1 unit, 2.05 (1.41 to 2.98; n=6) for a 10% higher percentage body fat, 1.09 (1.05 to 1.13, n=5) for an increase in body shape index of 0.005 units, 2.55 (1.59 to 4.10, n=4) for a 10% higher body adiposity index, and 1.11 (0.98 to 1.27; n=14) for a 10 cm larger hip circumference. A strong positive linear association was found between body mass index and the risk of type 2 diabetes. Positive linear or monotonic associations were also found in all regions and ethnicities, without marked deviation from linearity at a specific cut-off value. Indices of central fatness, independent of overall adiposity, also had positive linear or monotonic associations with the risk of type 2 diabetes. Positive linear or monotonic associations were also found for total and visceral fat mass, although the number of studies was small. Conclusions A higher body mass index was associated with a greater risk of developing type 2 diabetes. A larger waist circumference, independent of overall adiposity, was strongly and linearly associated with the risk of type 2 diabetes. Systematic review registration PROSPERO CRD42021255338.

Novel lipid indicators and the risk of type 2 diabetes mellitus among Chinese hypertensive patients: findings from the Guangzhou Heart Study

“…A meta-analysis included ten observational studies involving 112,603 participants found that VAI may be related to a high risk of prediabetes [ 55 ]. A recent meta-analysis included nine cohort studies showed that each 1-unit increment of VAI was associated with 42% higher risk of T2DM [ 25 ]. Yu et al also conducted a cohort analysis and found that high-VAI level was associated with increased risk of new-onset T2DM [ 56 ].…”

The lipid accumulation product is a powerful tool to diagnose metabolic dysfunction-associated fatty liver disease in the United States adults

“…In summary, it is difficult to identify patients with MAFLD early and accurately based on BMI alone, so it is necessary to find better indicators of central obesity and insulin resistance (IR) to assist in the diagnosis of MAFLD. Easy-to-calculate and accessible anthropometric indicators such as lipid accumulation product (LAP), body roundness index (BRI), visceral fat index (VAI), cone index (CI), and body fat index (BAI) have been used as proxies for IR and central obesity and can quantify visceral fat status (20)(21)(22). In addition, the CMI, triglyceride-glucose (TyG) index, and hepatic steatosis index (HSI) have been confirmed to reflect adiposity and IR (23)(24)(25).…”

Risk Stratification Based on a Pattern of Immunometabolic Host Factors Is Superior to Body Mass Index—Based Prediction of COVID-19-Associated Respiratory Failure

“…The high prevalence and increasing incidence rates of overweight and obesity are major public health problems in Western societies due to their association with pathologies such as diabetes, cardiovascular diseases, and cancer [ 1 , 2 , 3 , 4 ]. On the other hand, overweight and obesity are also risk factors for a number of infectious diseases [ 5 ] and are associated with higher frequencies of nosocomial infections, including respiratory tract infections and pneumonia, as again recently discussed for COVID-19 patients [ 5 , 6 , 7 ].…”